Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

Friday, June 7, 2024 BiopharmaWatch Research 1 min read

Key Takeaway: Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

Price reaction · baseline $55.05 (2024-06-06 close) · hit after-hours · clean, no other SOLV news in the window

day 0 close · peak

+2.5%

Full Press Release Details

Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer".